Obesity Impact on Dyspnea in COPD Patients
International Journal of Chronic Obstructive Pulmonary Disease · 2024
DOI: 10.2147/copd.s450366 ↗At a glance
Beobachtungsstudie in International Journal of Chronic Obstructive Pulmonary Disease, 2024. Written by Alexis Dupuis and 7 co-authors. Institution: Department of Respiratory Diseases, University Hospital of Reims, Reims, France. Major MEDLINE topics: Dyspnea, Obesity, Pulmonary Disease, Chronic Obstructive. Cited 4 times so far (Crossref); 55 references. The full text is freely available (open access, CC BY-NC 3.0).
Topics: COPD
Abstract (original language)
Background
The role of obesity on dyspnea in chronic obstructive pulmonary disease (COPD) patients remains unclear. We aimed to provide an assessment of dyspnea in COPD patients according to their Body Mass Index (BMI) and to investigate the impact of obesity on dyspnea according to COPD severity.
Methods
One hundred and twenty seven COPD patients with BMI ≥ 18.5 kg/m² (63% male, median (interquartile range) post bronchodilator forced expiratory volume of 1 second (post BD FEV1) at 51 (34-66) % pred) were consecutively included. Dyspnea was assessed by mMRC (Modified medical research council) scale. Lung function tests were recorded, and emphysema was quantified on CT-scan (computed tomography-scan).
Results
Twenty-five percent of the patients were obese (BMI ≥ 30kg/m²), 66% of patients experienced disabling dyspnea (mMRC ≥ 2). mMRC scores did not differ depending on BMI categories (2 (1-3) for normal weight, 2 (1-3) 1 for overweight and 2 (1-3) for obese patients; p = 0.71). Increased mMRC scores (0-1 versus 2-3 versus 4) were associated with decreased post BD-FEV1 (p < 0.01), higher static lung hyperinflation (inspiratory capacity/total lung capacity (IC/TLC), p < 0.01), reduced DLCO (p < 0.01) and higher emphysema scores (p < 0.01). Obese patients had reduced static lung hyperinflation (IC/TLC p < 0.01) and lower emphysema scores (p < 0.01) than non-obese patients. mMRC score increased with GOLD grades (1-2 versus 3-4) in non-obese patients but not in obese patients, in association with a trend towards reduced static lung hyperinflation and lower emphysema scores.
Conclusion
By contrast with non-obese patients, dyspnea did not increase with spirometric GOLD grades in obese patients. This might be explained by a reduced lung hyperinflation related to the mechanical effects of obesity and a less severe emphysema in severe COPD patients with obesity.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Respiratory Diseases, University Hospital of Reims, Reims, France.
- Université de Reims Champagne-Ardenne, VieFra, CHU Reims, Unité d'Aide Méthodologique, Reims, F-51100, France.
- University of Reims Champagne-Ardenne (URCA), Inserm UMR-S 1250, SFR Cap-Santé, Reims, France.
ORCID profiles: Jeanne-Marie Perotin, Julien Ancel, Valérian Dormoy
Cite
APA
Dupuis, A., Thierry, A., Perotin, J. M., Ancel, J., Dormoy, V., Dury, S., Deslée, G., & Launois, C. (2024). Obesity Impact on Dyspnea in COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease. https://doi.org/10.2147/copd.s450366
Vancouver
Dupuis A, Thierry A, Perotin JM, Ancel J, Dormoy V, Dury S, et al. Obesity Impact on Dyspnea in COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease. 2024. doi:10.2147/copd.s450366
BibTeX
@article{Dupuis2024,
author = {Dupuis, Alexis and Thierry, Aurore and Perotin, Jeanne-Marie and Ancel, Julien and Dormoy, Valérian and Dury, Sandra and Deslée, Gaëtan and Launois, Claire},
title = {Obesity Impact on Dyspnea in COPD Patients},
journal = {International Journal of Chronic Obstructive Pulmonary Disease},
year = {2024},
doi = {10.2147/copd.s450366}
}
EUVIMED